Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0U0FH
|
|||
Former ID |
DIB003801
|
|||
Drug Name |
Amitivir
|
|||
Synonyms |
LY-217896
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Virus infection [ICD-11: 1A24-1D9Z] | Terminated | [1] | |
Company |
Eli Lilly & Co
|
|||
Structure |
Download2D MOL |
|||
Formula |
C3H2N4S
|
|||
Canonical SMILES |
C1=NN=C(S1)NC#N
|
|||
InChI |
1S/C3H2N4S/c4-1-5-3-7-6-2-8-3/h2H,(H,5,7)
|
|||
InChIKey |
YUCHAYRHHXJNQK-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 111393-84-1
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Herpes simplex virus DNA polymerase UL30 (HSV UL30) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001039) | |||
REF 2 | Approaches and strategies for the treatment of influenza virus infections. Antivir Chem Chemother. 1999 Jul;10(4):155-85. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.